Role of p53 in drug resistance in ovarian cancer.

Lancet (London, England) ·Vol. 349 ·No. 9054 ·1997-03-15 ·Pages 744-5

Shelling AN

Abstract

暂无摘要

MeSH Terms

Apoptosis/genetics Drug Resistance, Neoplasm/genetics Female Genes, p53/genetics Humans Mutation Ovarian Neoplasms/drug therapy,genetics Prognosis

Authors & Affiliations

1 authors, click to expand affiliations / ORCID

Shelling A N

National Women's Hospital, Auckland, New Zealand.

Article Info

Journal

Lancet (London, England)

Abbr.

Lancet

ISSN

0140-6736

DOI

Published

1997-03-15

Pages

744-5

Language

English

Region

England

NLM ID

2985213R

Subset

Corrections

CommentIn

PMID: 9167490

External Links

Analysis Services